Chittaranjan Andrade1. Show Affiliations » 1. Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com
Abstract
Entities: Chemical Disease
Mesh： See more » Antipsychotic Agents/adverse effectsAntipsychotic Agents/pharmacokineticsAntipsychotic Agents/therapeutic useBenzhydryl Compounds/adverse effectsBenzhydryl Compounds/therapeutic useCentral Nervous System Stimulants/adverse effectsCentral Nervous System Stimulants/therapeutic useCytochrome P-450 CYP1A2/bloodCytochrome P-450 CYP3A/bloodDisease ProgressionDisorders of Excessive Somnolence/diagnosisDisorders of Excessive Somnolence/drug therapyDisorders of Excessive Somnolence/psychologyDose-Response Relationship, DrugDrug InteractionsDrug Therapy, CombinationEnzyme Induction/drug effectsFollow-Up StudiesHumansMaleMiddle AgedModafinilObesity/bloodObesity/complicationsObesity/psychologyRisk FactorsSchizophrenia/diagnosisSchizophrenia/drug therapySchizophrenia/enzymologySchizophrenic PsychologySleep Apnea, Obstructive/diagnosisSleep Apnea, Obstructive/drug therapySleep Apnea, Obstructive/psychology
Substances： See more » Antipsychotic AgentsBenzhydryl CompoundsCentral Nervous System StimulantsCYP1A2 protein, humanCytochrome P-450 CYP1A2Cytochrome P-450 CYP3ACYP3A4 protein, humanModafinil
Year: 2012 PMID： 22967783 DOI： 10.4088/JCP.12f07977
Source DB: PubMed Journal: J Clin Psychiatry ISSN： 0160-6689 Impact factor: 4.384